APA

Zwaan C. M., Reinhardt D., Corbacioglu S., van Wering E. R., Bökkerink J. P. M., Tissing W. J. E., Samuelsson U., Feingold J., Creutzig U. & Kaspers G. J. L. (20030718). Gemtuzumab ozogamicin: first clinical experiences in children with relapsed/refractory acute myeloid leukemia treated on compassionate-use basis. : Blood.

Chicago

Zwaan Christian M, Reinhardt Dirk, Corbacioglu Selim, van Wering Elisabeth R, Bökkerink Jos P M, Tissing Wim J E, Samuelsson Ulf, Feingold Jay, Creutzig Ursula and Kaspers Gertjan J L. 20030718. Gemtuzumab ozogamicin: first clinical experiences in children with relapsed/refractory acute myeloid leukemia treated on compassionate-use basis. : Blood.

Harvard

Zwaan C. M., Reinhardt D., Corbacioglu S., van Wering E. R., Bökkerink J. P. M., Tissing W. J. E., Samuelsson U., Feingold J., Creutzig U. and Kaspers G. J. L. (20030718). Gemtuzumab ozogamicin: first clinical experiences in children with relapsed/refractory acute myeloid leukemia treated on compassionate-use basis. : Blood.

MLA

Zwaan Christian M, Reinhardt Dirk, Corbacioglu Selim, van Wering Elisabeth R, Bökkerink Jos P M, Tissing Wim J E, Samuelsson Ulf, Feingold Jay, Creutzig Ursula and Kaspers Gertjan J L. Gemtuzumab ozogamicin: first clinical experiences in children with relapsed/refractory acute myeloid leukemia treated on compassionate-use basis. : Blood. 20030718.